STEPHANIE SOSA: Open Payments
NPI 1750898136 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$490 in 9 payments from 8 companies in 2025. Trend: 2023 $994 · 2024 $266 · 2025 $490
Food & beverage: $490
| Company | Payments | Amount |
|---|---|---|
| BeOne Medicines USA, Inc. | 1 | $131 |
| BeiGene USA, Inc. | 1 | $125 |
| Legend Biotech USA Inc. | 1 | $88 |
| SANOFI-AVENTIS U.S. LLC | 2 | $46 |
| Dendreon Pharmaceuticals LLC | 1 | $28 |
| Adaptive Biotechnologies Corporation | 1 | $27 |
| Incyte Corporation | 1 | $23 |
| PFIZER INC. | 1 | $21 |
Products named: BRUKINSA, CARVYKTI, REZUROCK, PROVENGE, clonoSEQ, JAKAFI, ELREXFIO.
Industry payments across FL — which companies pay providers there.
